help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GARCÍA-RÍO, F.
Right arrow Articles by VILLAMOR, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GARCÍA-RÍO, F.
Right arrow Articles by VILLAMOR, J.

Am. J. Respir. Crit. Care Med., Volume 164, Number 5, September 2001, 852-857

Reduction of Lung Distensibility in Acromegaly after Suppression of Growth Hormone Hypersecretion

FRANCISCO GARCÍA-RÍO, JOSÉ M. PINO, JUAN J. DÍEZ, ANTONIO RUÍZ, CARLOS VILLASANTE, and JOSÉ VILLAMOR

Pulmonary Service and Endocrinology Service, Hospital Universitario La Paz, Madrid, Spain

Whether the growth of the lungs in acromegaly is due to alveolar hypertrophy or alveolar hyperplasia is a subject of debate. To discriminate these hypotheses, we compared pulmonary distensibility and diffusing capacity among 11 patients with active acromegaly and 11 matched control subjects, evaluating the response of pulmonary distensibility and diffusing capacity to suppression of growth hormone (GH) hypersecretion. We performed lineal and exponential analyses of quasistatic pressure-volume curves. Patients with active acromegaly had a greater TLC, lung compliance, and shape constant, K, than did normal subjects. We found no significant differences between the study groups in carbon monoxide diffusing capacity or diffusing capacity per unit of alveolar volume. After treatment, patients with inactive acromegaly showed a reduced TLC (6.95 ± 1.40 [mean ± SD] L versus 6.35 ± 1.23 L), reduced lung compliance (3.61 ± 0.90 L/kPa versus 2.36 ± 0.79 L/ kPa), reduced K coefficient (2.62 ± 0.65 kPa-1 versus 1.35 ± 0.40 kPa-1), and increased maximal recoil pressure (1.74 ± 0.38 kPa versus 2.28 ± 0.25 kPa). We conclude that the increased lung distensibility with normal diffusion capacity demonstrated in patients with active acromegaly, which was partly reversible after suppression of GH hypersecretion, suggests that lung growth in acromegaly may result from an increase in alveolar size.

Keywords: lung volume measurements; lung compliance; pulmonary gas exchange; somatotropin; acromegaly




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
Mechanisms and Limits of Induced Postnatal Lung Growth
Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 319 - 343.
[Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. Colao, D. Ferone, P. Marzullo, and G. Lombardi
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Endocr. Rev., February 1, 2004; 25(1): 102 - 152.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Ben-Shlomo and S. Melmed
The Role of Pharmacotherapy in Perioperative Management of Patients with Acromegaly
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 963 - 968.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Sleep-Disordered Breathing, Control of Breathing, Respiratory Muscles, and Pulmonary Function Testing in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 584 - 597.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society 		  New Orleans Int'l Conf